Compare DAIO & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAIO | MODD |
|---|---|---|
| Founded | 1969 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 33.3M |
| IPO Year | 1995 | 2019 |
| Metric | DAIO | MODD |
|---|---|---|
| Price | $2.86 | $0.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.22 | N/A |
| AVG Volume (30 Days) | 21.1K | ★ 185.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.62 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,769,000.00 | N/A |
| Revenue This Year | $7.40 | N/A |
| Revenue Next Year | $2.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $0.28 |
| 52 Week High | $3.49 | $1.29 |
| Indicator | DAIO | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 56.63 |
| Support Level | $2.56 | $0.43 |
| Resistance Level | $2.90 | $0.52 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 18.04 | 54.17 |
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.